Last reviewed · How we verify
NCT04761328
Fear of Recurrence and Stopping Immunotherapy
NA trial testing cognitive behavioral therapy in Cognitive Behavioral Therapy in 100 participants. Currently enrolling.
31 December 2027
Quick facts
| Lead sponsor | University of Pittsburgh |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 100 |
| Start date | 2 August 2021 |
| Primary completion | 31 December 2027 |
| Estimated completion | 31 December 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- cognitive behavioral therapy
Conditions studied
- Cognitive Behavioral Therapy — all drugs for Cognitive Behavioral Therapy →
Sponsor
University of Pittsburgh
Who can join
21 and older, any sex, with Cognitive Behavioral Therapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04761328
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of cognitive behavioral therapy
Trials testing the same drug.
- NCT07281352 — RCT of Psilocybin-assisted CBT for Depression · Phase 1, PHASE2 · recruiting
- NCT06208111 — A Clinical Trial of Cognitive Behavior Therapy for Depression, Stigmatization, Excessive Worries, and Emotional Manageme · NA · unknown
- NCT06064032 — Cognitive Behavioral Therapy And Motor Learning Technique Among Attention Deficit Hyperactivity Disorder Adults · NA · unknown
- NCT06013085 — Effects of Cognitive-behavioral Therapy for Insomnia in Nurses With Post Covid-19 Condition · NA · not yet recruiting
- NCT05593796 — Cognitive Behavioral Therapy(CBT) in Treatment of Methamphetamine Use Disorder · NA · unknown
Other recruiting trials for Cognitive Behavioral Therapy
Currently open trials in the same condition.
- NCT07232823 — Brief Culturally Adapted CBT for OCD · NA · recruiting
- NCT06454695 — Improving Treatment of Major Depressive Disorder by Reducing Negative Future-Oriented Mental Imagery · NA · recruiting
- NCT06521957 — Effectiveness of CBT in Improving Psycho-Neuro-Endocrine Factors in Women Following In Vitro Fertilization Program · NA · recruiting
- NCT05609916 — CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD · NA · recruiting
- NCT04700878 — A Randomized Controlled Evaluation of a Compassion-course for Healthcare Professionals · NA · recruiting
Other University of Pittsburgh trials
Trials by the same sponsor.
- NCT05601206 — Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE · NA · not yet recruiting
- NCT06652815 — Cognition, Metacognition, and Stigma in Patients With Suicidal Ideation · not yet recruiting
- NCT06474286 — Prucalopride for Cognitive Functioning in Schizophrenia · NA · not yet recruiting
- NCT06488469 — Behavioural Problems and Cognition in Children With Hypoglycemia Unawareness in Type-1 Diabetes Mellitus · NA · not yet recruiting
- NCT06652802 — Effectiveness of Nurse-Conducted Brief Intervention (NCBI) Supplemented With Mobile for Preventing Alcohol Use Disorders · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04761328 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Pittsburgh
- Last refreshed: 5 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04761328.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing